NCT07208214View on ClinicalTrials.gov

Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance.

NANot yet recruitingINTERVENTIONAL

Enrollment

242

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions

IBD

Interventions

DIAGNOSTIC_TEST

TXI

"Participants allocated to the TXI group undergo withdrawal using Texture and Colour Enhancement Imaging, while those in the Dye group receive withdrawal with Dye chromoendoscopy. Both procedures follow standardized protocols outlined in the study design."

All Listed Sponsors

lead

London North West Healthcare NHS Trust

OTHER

NCT07208214 - Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance. | Biotech Hunter | Biotech Hunter